CASI Pharmaceuticals
CASI
#10853
Rank
A$6.1 M
Marketcap
A$0.30
Share price
0.00%
Change (1 day)
-86.26%
Change (1 year)

EPS for CASI Pharmaceuticals (CASI)

EPS in 2025 (TTM): A-$4.22

According to CASI Pharmaceuticals's latest financial reports the company's current EPS (TTM) is A-$3.97. In 2024 the company made an earnings per share (EPS) of A-$3.67 a decrease over its 2023 EPS that were of A-$2.89.

EPS history for CASI Pharmaceuticals from 1996 to 2025

Annual EPS

Year EPS Change
2025 (TTM)A-$4.2215.16%
2024A-$3.6726.73%
2023A-$2.89-32.89%
2022A-$4.3111.9%
2021A-$3.85-38.44%
2020A-$6.26-8.96%
2019A-$6.8750%
2018A-$4.5877.78%
2017A-$2.585.88%
2016A-$2.43-22.73%
2015A-$3.15-76.09%
2014A-$13.17318.18%
2013A-$3.15-71.79%
2012A-$11.1765.96%
2011A-$6.73-50%
2010A-$13.46-18.97%
2009A-$16.61-63.64%
2008A-$45.683.57%
2007A-$44.11-60.56%
2006A-$111.8497.22%
2005A-$56.71-2.7%
2004A-$58.28-45.59%
2003A-$107.11-61.8%
2002A-$280.39-25.52%
2001A-$376.47-21.38%
2000A-$478.8613.86%
1999A-$420.58149.53%
1998A-$168.5598.15%
1997A-$85.0610.2%
1996A-$77.18